Evidence mapPaperPMID 39961078Full record

ArticlePhysiological genomics2025

Developmental pyrethroid exposure disrupts molecular pathways for MAP kinase and circadian rhythms in mouse brain.

Jennifer H Nguyen, Melissa A Curtis, Ali S Imami, William G Ryan, Khaled Alganem, Kari L Neifer, Nilanjana Saferin, Charlotte N Nawor, Brian P Kistler, Gary W Miller and 3 more

Abstract read
In one paragraph

Article in Physiological genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Pathway Analysis Interpretation in the Multi-Omic Era.Biotech (Basel (Switzerland)) · 2025
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Jennifer H NguyenDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.
Melissa A CurtisDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.
Ali S ImamiDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.ORCID 0000-0003-3684-3539
William G RyanDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.
Khaled AlganemDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.
Kari L NeiferDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.ORCID 0000-0002-3691-3851
Nilanjana SaferinDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.
Charlotte N NaworDepartment of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.
Brian P KistlerDepartment of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.
Gary W MillerDepartment of Environmental Health, Emory Rollins School of Public Health, Atlanta, Georgia, United States.ORCID 0000-0001-8984-1284
Rammohan ShuklaDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.
Robert E McCullumsmithDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.
James P BurkettDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.ORCID 0000-0002-6357-5499

Funding

Translational assessment of brain bioenergetic function in schizophreniaR01MH121102 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI Christopher Marano, Robert E McCullumsmith · 2021 to 2024
$2.9M
Vesicular modulation of dopamine neuron toxicityR01ES023839 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2023 to 2025
$1.4M
Cross platform analysis of drug targets and toxicity of bath saltsU01DA054330 · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · 2025 to 2025
$556k
The effect of SHANK3 mutation in transgenic prairie voles on natural social behaviors and genetic mechanismsR21MH127500 · NIMH · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI James Burkett, Benjamin James Dantzer · 2023 to 2023
$150k
HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) R00ES027869HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) R01ES023839HHS | NIH | National Institute of General Medical Sciences (NIGMS) T32GM144873HHS | NIH | National Institute of Mental Health (NIMH) R01MH107487HHS | NIH | National Institute of Mental Health (NIMH) R01MH121102HHS | NIH | National Institute on Drug Abuse (NIDA) U01DA054330NIDA NIH HHS U01 DA054330NIEHS NIH HHS R00 ES027869NIEHS NIH HHS R01 ES023839NIEHS NIH HHS R21 ES036352NIGMS NIH HHS T32 GM144873NIMH NIH HHS R01 MH107487NIMH NIH HHS R01 MH121102NIMH NIH HHS R21 MH127500
6 · The paper itself

Abstract

Neurodevelopmental disorders (NDDs) are a category of pervasive disorders of the developing nervous system with few or no recognized biomarkers. A significant portion of the risk for NDDs, including attention deficit hyperactivity disorder (ADHD), is contributed by the environment, and exposure to pyrethroid pesticides during pregnancy has been identified as a potential risk factor for NDD in the unborn child. We recently showed that low-dose developmental exposure to the pyrethroid pesticide deltamethrin in mice causes male-biased changes to ADHD- and NDD-relevant behaviors as well as the striatal dopamine system. Here, we used an integrated multiomics approach to determine the broadest possible set of biological changes in the mouse brain caused by developmental pyrethroid exposure (DPE). Using a litter-based, split-sample design, we exposed mouse dams during pregnancy and lactation to deltamethrin (3 mg/kg or vehicle every 3 days) at a concentration well below the EPA-determined benchmark dose used for regulatory guidance. We raised male offspring to adulthood, euthanized them, and pulverized and divided whole brain samples for split-sample transcriptomics, kinomics, and multiomics integration. Transcriptome analysis revealed alterations to multiple canonical clock genes, and kinome analysis revealed changes in the activity of multiple kinases involved in synaptic plasticity, including the mitogen-activated protein (MAP) kinase ERK. Multiomics integration revealed a dysregulated protein-protein interaction network containing primary clusters for MAP kinase cascades, regulation of apoptosis, and synaptic function. These results demonstrate that DPE causes a multimodal biophenotype in the brain relevant to ADHD and identifies new potential mechanisms of action.

Indexed as

BrainCircadian RhythmMAP Kinase Signaling SystemPyrethrinsAnimalsFemaleMaleMiceMice, Inbred C57BLNitrilesPregnancyPrenatal Exposure Delayed EffectsdecamethrinNitrilesPyrethrinscircadian rhythmskinomicsMAP kinasemultiomics integrationtranscriptomics

Identifiers

PMID39961078
PMCPMC12232972

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.